HiberGene’s PCR Adapt COVID-19/Flu Combo is an RT-qPCR test for the direct detection and differentiation of SARS-CoV-2, Influenza A and Influenza B nucleic acid sequences in human nasopharyngeal samples, without sample extraction.

Benefits:

• Detects two separate SARS-CoV-2 genes (N & Orf1ab)
• FAST detection (70-80 Mins)
• ACCURATE diagnosis:
  98-100% sensitivity, 100% specificity
• EASY – Low-complexity direct testing protocol
• Multi-platform compatibility
• High throughput capacity

Clinical Sensitivity & Specificity – BioRad CFX96:

Product Features:

Protocol: